Tech Times of New York
SEE OTHER BRANDS

Hottest science and technology news from New York

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on June 12, 2025

FOBI AI Inc. Announces Closing of the Sale of German Subsidiary

FOBI AI Inc. Announces Closing of the Sale of German Subsidiary

Vancouver, BC, June 12, 2025 (GLOBE NEWSWIRE) -- FOBI AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (“Fobi” or the “Company”) announces that further to its news release dated May 28, 2025, it has closed the sale (the “Transaction”) of all of its shares in Fobi AI …

DraftKings to Introduce Transaction Fee in Illinois

DraftKings to Introduce Transaction Fee in Illinois

BOSTON, June 12, 2025 (GLOBE NEWSWIRE) -- In response to the recent and prior sports wagering tax increases passed by the Illinois state legislature on all mobile and online sports wagers placed with licensed operators, DraftKings Inc. (Nasdaq: DKNG) today …

Xometry Announces Convertible Debt Refinancing and Closing of $250 Million of 0.75% Convertible Senior Notes Offering

Xometry Announces Convertible Debt Refinancing and Closing of $250 Million of 0.75% Convertible Senior Notes Offering

Issued $250 million principal amount of convertible notes due in 2030, with the proceeds used in part to retire approximately $202 million principal amount of existing convertible notes due in 2027 Opportunistic refinancing extends the maturity of most of …

Draganfly Announces Closing of US$13.75 Million Public Offering

Draganfly Announces Closing of US$13.75 Million Public Offering

Saskatoon, SK., June 12, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the closing of its previously announced public offering (the “ …

InterDigital Declares Regular Quarterly Cash Dividend

InterDigital Declares Regular Quarterly Cash Dividend

WILMINGTON, Del., June 12, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.60 …

Host Hotels & Resorts Announces Second Quarter Dividend

Host Hotels & Resorts Announces Second Quarter Dividend

BETHESDA, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Host Hotels …

À la clôture de son offre publique, Aduro Clean Technologies annonce la levée de 8 millions de dollars

À la clôture de son offre publique, Aduro Clean Technologies annonce la levée de 8 millions de dollars

LONDON, Ontario, 12 juin 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. ci-après « Aduro » ou la « Société » (Nasdaq : ADUR) (CSE :ACT) (FSE : 9D5), une société de technologie propre qui recycle chimiquement les matières premières de moindre valeur …

Aduro Clean Technologies gibt den Abschluss einer öffentlich garantierten Emission im Wert von 8 Millionen US-Dollar bekannt

Aduro Clean Technologies gibt den Abschluss einer öffentlich garantierten Emission im Wert von 8 Millionen US-Dollar bekannt

LONDON, Ontario, June 12, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Clean-Tech-Unternehmen, das die Kraft der Chemie nutzt, um minderwertige Rohstoffe wie …

New York Mortgage Trust Declares Second Quarter 2025 Common Stock Dividend of $0.20 Per Share, and Preferred Stock Dividends

New York Mortgage Trust Declares Second Quarter 2025 Common Stock Dividend of $0.20 Per Share, and Preferred Stock Dividends

NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.20 per share on shares of its common stock …

Hub Group Declares Quarterly Dividend

Hub Group Declares Quarterly Dividend

OAK BROOK, Ill., June 12, 2025 (GLOBE NEWSWIRE) -- Hub Group, Inc. (Nasdaq: HUBG) today announced its Board of Directors declared a quarterly cash dividend of $0.125 per share on the Company’s Class A and Class B Common Stock. The dividend is scheduled to …

Nano Dimension Reports First Quarter 2025 Financial Results

Nano Dimension Reports First Quarter 2025 Financial Results

Core Business Revenue of $14.4 Million, 8% Higher Year-Over-Year Conference Call Today at 4:30 PM EDT WALTHAM, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital …

DBV Technologies participera au prochain congrès EAACI 2025

DBV Technologies participera au prochain congrès EAACI 2025

Châtillon, France, le 12 juin (22:30 CEST) 2025 DBV Technologies participera au prochain congrès EAACI 2025 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT ; CUSIP : 23306J309), une société biopharmaceutique en phase …

DBV Technologies to Participate in Upcoming EAACI Congress 2025

DBV Technologies to Participate in Upcoming EAACI Congress 2025

Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today …

FibroGen Announces 1-for-25 Reverse Stock Split

FibroGen Announces 1-for-25 Reverse Stock Split

SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on …

Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL

Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL

Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities Of the 64 patients enrolled, 61 received treatment, …

Galapagos zal nieuwe ATALANTA-1 CAR-T data presenteren op EHA 2025, met lage toxiciteit en snelle, gedecentraliseerde toediening van vers, early-memory-verrijkt GLPG5101 bij R/R NHL

Galapagos zal nieuwe ATALANTA-1 CAR-T data presenteren op EHA 2025, met lage toxiciteit en snelle, gedecentraliseerde toediening van vers, early-memory-verrijkt GLPG5101 bij R/R NHL

Gegevens uit de lopende ATALANTA-1 fase 1/2-studie bij een zwaar voorbehandelde patiëntengroep met recidief/refractair non-Hodgkinlymfoom (R/R NHL) tonen lage percentages van hooggradige toxiciteiten aan Van de 64 ingeschreven patiënten werden er 61 …

Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment

Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment

Gabrail Cancer …

B2Gold 2025 Annual General and Special Meeting Details and Voting Reminder

B2Gold 2025 Annual General and Special Meeting Details and Voting Reminder

VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) is scheduled to hold its 2025 Annual General and Special Meeting of Shareholders (the “Meeting”) on Thursday, …

Yoshiharu Announces New Executives and Board Appointments

Yoshiharu Announces New Executives and Board Appointments

Ji-Won Kim to Serve as Sole Chief Executive Officer Seasoned Public Accountants John Oh, New Chief Financial Officer, and Young-Soo Choi, New Independent Director, to Lead Comprehensive Strategic Initiatives BUENA PARK, Calif., June 12, 2025 (GLOBE …

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman

SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired Rocket …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service